logo

For the Inventor, By the Inventor

Gaithersburg, MD, United States of America

Amir H Shojaei

This inventor holds 4 USPTO granted patents, plus 1 CIPO patent. Top assignee: Shire Laboratories, Inc.. Active years: 2004-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amir H Shojaei. Retrieved from https://idiyas.com/inventor/amir-h-shojaei

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4


Average Co-Inventor Count = 3.2

ph-index = 4

Forward Citations = 118(Granted Patents)


Company Filing History:

goldMedal4 out of 25 
 
Shire Laboratories, Inc.
 patents

Years Active: 2004-2006

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents
1. 7022337 - Self-emulsifying formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability and/or reduced food effect (2006-04-04),
2. 7011846 - Oral capsule formulation with increased physical stability (2006-03-14),
3. 6890918 - Pharmaceutical compositions including ACE/NEP inhibitors and bioavailability enhancers (2005-05-10),
4. 6772801 - Fluidization of particles for encapsulation in oral dosage pharmaceutical products (2004-08-10),

Title: Innovations by Amir H Shojaei

Introduction

Amir H Shojaei is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations that enhance the bioavailability of active agents. With a total of 4 patents to his name, his work has the potential to impact the treatment of various health conditions.

Latest Patents

Amir's latest patents include innovative formulations aimed at improving oral bioavailability. One of his notable inventions is a self-emulsifying formulation of fenofibrate and/or fenofibrate derivatives. This formulation is designed to provide improved bioavailability compared to commercially available options, making it beneficial for treating hypercholesterolaemia or hypertriglyceridaemia in mammals. Another significant patent involves an oral capsule formulation that enhances physical stability. This formulation utilizes a non-aqueous solubilizer and a stabilizing agent to maintain capsule integrity for at least 24 hours, ensuring effective delivery of hydrophobic pharmaceutically active agents.

Career Highlights

Amir H Shojaei is currently employed at Shire Laboratories, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on developing formulations that address critical challenges in drug delivery and efficacy. His contributions have been instrumental in advancing the field and improving patient outcomes.

Collaborations

Amir has collaborated with several professionals in his field, including Scott A Ibrahim and Beth A Burnside. These collaborations have fostered a productive environment for innovation and have led to the development of groundbreaking formulations.

Conclusion

Amir H Shojaei's work exemplifies the importance of innovation in the pharmaceutical industry. His patents reflect a commitment to improving drug formulations and enhancing patient care. Through his efforts, he continues to make a significant impact in the field of pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…